tradingkey.logo

Alignment Healthcare Inc

ALHC

16.770USD

-0.949-5.36%
收盤 05/01, 16:00美東報價延遲15分鐘
3.22B總市值
虧損本益比TTM

Alignment Healthcare Inc

16.770

-0.949-5.36%
關於 Alignment Healthcare Inc 公司
Alignment Healthcare, Inc. 提供以消費者爲中心的醫療保健平臺,旨在爲老年人提供醫療保健服務。該公司的業務包括加利福尼亞州、北卡羅來納州、內華達州、亞利桑那州、佛羅里達州和德克薩斯州的醫療保險優勢計劃。其消費者品牌 Alignment Health 提供 50 多個醫療保險優勢計劃,服務於六個州的 53 個縣。該公司與全國知名和本地供應商合作,提供協調護理,由其定製護理模式、24/7 禮賓護理團隊和專用技術 Alignment 的虛擬應用程序 (AVA) 提供支持。AVA 專爲老年人護理而設計,提供醫療保健生態系統的端到端協調。AVA 的工具和服務套件建立在統一的數據架構內。醫療保險優勢計劃直接面向消費者,爲醫院保險福利、門診服務和處方藥保險提供單點護理服務。
公司簡介
公司代碼ALHC
公司名稱Alignment Healthcare Inc
上市日期Mar 26, 2021
成立日期2014
CEOMr. John E. Kao
員工數量1679
證券類型Ordinary Share
年結日Mar 26
公司地址1100 W. Town And Country Road
城市ORANGE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編92868
電話18443102247
網址https://www.alignmenthealth.com/
公司代碼ALHC
上市日期Mar 26, 2021
成立日期2014
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
Mr. Sebastian Burzacchi
Mr. Sebastian Burzacchi
Chief Operating Officer - Management Services Organization
Chief Operating Officer - Management Services Organization
250.38K
+15.17%
Ms. Margaret M. (Meg) Mccarthy
Ms. Margaret M. (Meg) Mccarthy
Lead Independent Director
Lead Independent Director
95.38K
+14.75%
Ms. Jody L. Bilney
Ms. Jody L. Bilney
Independent Director
Independent Director
63.77K
+32.07%
Dr. Hyong (Ken) Kim, M.D.
Dr. Hyong (Ken) Kim, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
收入明細
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
2.70B
0.00%
業務
地區
暫無數據
股東統計
更新時間: 2月23日 週日
更新時間: 2月23日 週日
持股股東
股東類型
持股股東
股東統計
佔比
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
持股股東
股東統計
佔比
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
股東類型
股東統計
佔比
Private Equity
30.87%
Investment Advisor
24.88%
Investment Advisor/Hedge Fund
18.98%
Hedge Fund
13.57%
Individual Investor
6.17%
Research Firm
1.17%
Pension Fund
0.18%
Bank and Trust
0.15%
Sovereign Wealth Fund
0.15%
Other
3.88%
機構持股
更新時間: 2月22日 週六
更新時間: 2月22日 週六
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
354
190.62M
96.46%
+2.56M
2024Q4
366
185.10M
96.49%
-4.29M
2024Q3
361
175.79M
91.75%
-18.07M
2024Q2
350
177.50M
92.81%
-16.13M
2024Q1
345
173.65M
90.84%
-16.06M
2023Q4
340
174.44M
92.27%
-18.71M
2023Q3
340
173.65M
91.94%
-19.56M
2023Q2
331
172.91M
91.73%
-9.35M
2023Q1
320
174.26M
93.05%
-8.71M
2022Q4
312
177.19M
94.61%
+2.71M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
General Atlantic LLC
61.03M
31.81%
+37.42K
+0.06%
Mar 13, 2025
Fidelity Management & Research Company LLC
16.37M
8.53%
-535.68K
-3.17%
Dec 31, 2024
The Vanguard Group, Inc.
9.80M
5.11%
+166.84K
+1.73%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
8.65M
4.51%
+3.06M
+54.74%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
7.72M
4.03%
+600.44K
+8.43%
Dec 31, 2024
Wellington Management Company, LLP
7.44M
3.88%
+3.26M
+77.92%
Dec 31, 2024
Deerfield Management Company, L.P.
7.30M
3.81%
-3.55M
-32.71%
Dec 31, 2024
Kao (John E)
5.35M
2.79%
+2.18M
+68.63%
Mar 27, 2025
Hood River Capital Management LLC
4.95M
2.58%
+1.41M
+39.61%
Dec 31, 2024
Durable Capital Partners LP
4.59M
2.39%
-890.72K
-16.26%
Dec 31, 2024
查看更多
持股ETF
更新時間: 23 分鐘前
更新時間: 23 分鐘前
機構名稱
佔比
Innovator IBD 50 Fund ETF
3.35%
SPDR S&P Health Care Services ETF
2.36%
Counterpoint Quantitative Equity ETF
2.21%
Simplify Health Care ETF
1.73%
First Trust Small Cap Growth AlphaDEX Fund
0.86%
Federated Hermes MDT Small Cap Core ETF
0.56%
First Trust Small Cap Core Alphadex Fund
0.55%
Even Herd Long Short ETF
0.55%
Langar Global HealthTech ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.3%
查看更多
Innovator IBD 50 Fund ETF
佔比3.35%
SPDR S&P Health Care Services ETF
佔比2.36%
Counterpoint Quantitative Equity ETF
佔比2.21%
Simplify Health Care ETF
佔比1.73%
First Trust Small Cap Growth AlphaDEX Fund
佔比0.86%
Federated Hermes MDT Small Cap Core ETF
佔比0.56%
First Trust Small Cap Core Alphadex Fund
佔比0.55%
Even Herd Long Short ETF
佔比0.55%
Langar Global HealthTech ETF
佔比0.32%
iShares U.S. Healthcare Providers ETF
佔比0.3%
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有